CNE100000FN7
CNE100000FN7
SINOPHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 575.167.877.000 | 584.507.930.000 | 1.6% |
| Cost of Revenue | 533.495.864.000 | 540.252.540.000 | 1.3% |
| Gross Profit | 41.672.013.000 | 44.255.390.000 | 5.8% |
| 24.592.771.000 | 26.484.908.000 | 7.1% | |
| Operating Income | 17.079.242.000 | 17.770.482.000 | 3.9% |
| Pretax Income | 14.799.627.000 | 14.000.899.000 | 5.7% |
| Net Income Common Stockholders | 7.155.094.000 | 7.049.683.000 | 1.5% |
| -- | -- | -- | |
| -- | -- | -- |